SecBot SecBot
SECBOTREPLAY Home › Report › RVMDW

RVMDW · Revolution Medicines is conducting a $750 million common stock offering…

Revolution Medicines, Inc. · 424B5 filed Apr 13, 2026 at 16:39 ET

At the news

BEARISHIMPACT 7/10

424B5 filed Apr 13, 2026 at 16:39 ET

Revolution Medicines is conducting a $750 million common stock offering and a concurrent $250 million convertible note offering. The stock offering will dilute existing shareholders and increase capital, while the convertible notes add leverage and potential future dilution upon conversion.

  • Revolution Medicines is offering $750 million of common stock
  • Concurrently offering $250 million aggregate principal amount of convertible senior notes due 2033
  • The two offerings are not contingent on each other's completion
  • Stock offering will result in immediate dilution to new investors

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access